Phase 1 Dose Escalation Study of SBRT Using 3 Fractions for Locally Advanced Pancreatic Cancer

医学 不良事件通用术语标准 胰腺癌 毒性 核医学 剂量分馏 实体瘤疗效评价标准 肿瘤科 不利影响 放射治疗 临床研究阶段 癌症 放射科 内科学
作者
Marsha Reyngold,Sana D. Karam,Carla Hajj,Abraham J. Wu,John Cuaron,Stephanie Lobaugh,Ellen Yorke,Shannan Dickinson,Bernard L. Jones,Yevgeniy Vinogradskiy,Amita Shukla‐Dave,Richard Kinh Gian,Carlie S. Sigel,Zhigang Zhang,Christopher H. Crane,Karyn A. Goodman
出处
期刊:International Journal of Radiation Oncology Biology Physics [Elsevier BV]
卷期号:117 (1): 53-63 被引量:3
标识
DOI:10.1016/j.ijrobp.2023.03.036
摘要

Purpose The optimal dose and fractionation of stereotactic body radiation therapy (SBRT) for locally advanced pancreatic cancer (LAPC) have not been defined. Single-fraction SBRT was associated with more gastrointestinal toxicity, so 5-fraction regimens have become more commonly employed. We aimed to determine the safety and maximally tolerated dose of 3-fraction SBRT for LAPC. Methods and Materials Two parallel phase 1 dose escalation trials were conducted from 2016 to 2019 at Memorial Sloan Kettering Cancer Center and University of Colorado. Patients with histologically confirmed LAPC without distant progression after at least 2 months of induction chemotherapy were eligible. Patients received 3-fraction linear accelerator–based SBRT at 3 dose levels, 27, 30, and 33 Gy, following a modified 3+3 design. Dose-limiting toxicity, defined as grade ≥3 gastrointestinal toxicity within 90 days, was scored by National Cancer Institute Common Terminology Criteria for Adverse Events, version 4. The secondary endpoints included cumulative incidence of local failure (LF) and distant metastasis (DM), as well as progression-free and overall survival PFS and OS, respectively, toxicity, and quality of life (QoL) using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ‐C30) and the pancreatic cancer–specific QLQ‐PAN26 questionnaire. Results Twenty-four consecutive patients were enrolled (27 Gy: 9, 30 Gy: 8, 33 Gy: 7). The median (range) age was 67 (52-79) years, and 12 (50%) had a head/uncinate tumor location, with a median tumor size of 3.8 (1.1-11) cm and CA19-9 of 60 (1-4880) U/mL. All received chemotherapy for a median of 4 (1.4-10) months. There were no grade ≥3 toxicities. Two-year rates (95% confidence interval) of LF, DM, PFS, and OS were 31.7% (8.6%-54.8%), 70.2% (49.7%-90.8%), 20.8% (4.6%-37.1%), and 29.2% (11.0%-47.4%), respectively. Three- and 6-month QoL assessment showed no detriment. Conclusions For select patients with LAPC, dose escalation to 33 Gy in 3 fractions resulted in no dose-limiting toxicities, no detriments to QoL, and disease outcomes comparable with conventional RT. Further exploration of SBRT schemes to maximize tumor control while enabling efficient integration with systemic therapy is warranted. The optimal dose and fractionation of stereotactic body radiation therapy (SBRT) for locally advanced pancreatic cancer (LAPC) have not been defined. Single-fraction SBRT was associated with more gastrointestinal toxicity, so 5-fraction regimens have become more commonly employed. We aimed to determine the safety and maximally tolerated dose of 3-fraction SBRT for LAPC. Two parallel phase 1 dose escalation trials were conducted from 2016 to 2019 at Memorial Sloan Kettering Cancer Center and University of Colorado. Patients with histologically confirmed LAPC without distant progression after at least 2 months of induction chemotherapy were eligible. Patients received 3-fraction linear accelerator–based SBRT at 3 dose levels, 27, 30, and 33 Gy, following a modified 3+3 design. Dose-limiting toxicity, defined as grade ≥3 gastrointestinal toxicity within 90 days, was scored by National Cancer Institute Common Terminology Criteria for Adverse Events, version 4. The secondary endpoints included cumulative incidence of local failure (LF) and distant metastasis (DM), as well as progression-free and overall survival PFS and OS, respectively, toxicity, and quality of life (QoL) using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ‐C30) and the pancreatic cancer–specific QLQ‐PAN26 questionnaire. Twenty-four consecutive patients were enrolled (27 Gy: 9, 30 Gy: 8, 33 Gy: 7). The median (range) age was 67 (52-79) years, and 12 (50%) had a head/uncinate tumor location, with a median tumor size of 3.8 (1.1-11) cm and CA19-9 of 60 (1-4880) U/mL. All received chemotherapy for a median of 4 (1.4-10) months. There were no grade ≥3 toxicities. Two-year rates (95% confidence interval) of LF, DM, PFS, and OS were 31.7% (8.6%-54.8%), 70.2% (49.7%-90.8%), 20.8% (4.6%-37.1%), and 29.2% (11.0%-47.4%), respectively. Three- and 6-month QoL assessment showed no detriment. For select patients with LAPC, dose escalation to 33 Gy in 3 fractions resulted in no dose-limiting toxicities, no detriments to QoL, and disease outcomes comparable with conventional RT. Further exploration of SBRT schemes to maximize tumor control while enabling efficient integration with systemic therapy is warranted.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
大橙子发布了新的文献求助10
刚刚
星辰大海应助贝利亚采纳,获得10
刚刚
1秒前
sunny心晴完成签到 ,获得积分10
3秒前
独特的凝云完成签到 ,获得积分10
3秒前
TheDing完成签到,获得积分10
4秒前
传奇3应助lenetivy采纳,获得10
6秒前
积极的忆曼完成签到,获得积分10
7秒前
量子星尘发布了新的文献求助10
7秒前
酒剑仙完成签到,获得积分10
7秒前
YANGMJ完成签到,获得积分10
8秒前
xialuoke完成签到,获得积分10
8秒前
scinature发布了新的文献求助10
9秒前
9秒前
9秒前
小洪俊熙完成签到,获得积分10
11秒前
狄百招完成签到 ,获得积分10
11秒前
UU完成签到,获得积分10
12秒前
半夏完成签到,获得积分10
14秒前
Judy完成签到 ,获得积分10
14秒前
跳跳糖完成签到,获得积分10
15秒前
JS完成签到,获得积分10
16秒前
胡萝卜完成签到,获得积分10
17秒前
Hunter完成签到,获得积分10
17秒前
耍酷依玉完成签到,获得积分10
17秒前
luo完成签到,获得积分10
18秒前
大橙子发布了新的文献求助10
19秒前
唯爱薇儿完成签到,获得积分10
20秒前
scinature完成签到,获得积分10
20秒前
21秒前
SilverPlane完成签到,获得积分10
21秒前
ATOM完成签到,获得积分10
22秒前
宫跃然完成签到,获得积分10
22秒前
sciforce完成签到,获得积分10
23秒前
刻苦的黑米完成签到,获得积分10
25秒前
25秒前
songvv发布了新的文献求助10
25秒前
欢喜大白菜真实的钥匙完成签到 ,获得积分10
25秒前
小石头完成签到,获得积分10
26秒前
Wguan完成签到,获得积分10
26秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038201
求助须知:如何正确求助?哪些是违规求助? 3575940
关于积分的说明 11373987
捐赠科研通 3305747
什么是DOI,文献DOI怎么找? 1819274
邀请新用户注册赠送积分活动 892662
科研通“疑难数据库(出版商)”最低求助积分说明 815022